CSX Investing Cash Flow increased by 19.7% to -$567.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.4%, from -$647.00M to -$567.00M. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows a downward trend with a 11.0% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$230.00M | -$936.00M | -$414.00M | -$368.00M | -$651.00M | -$625.00M | -$419.00M | -$460.00M | -$485.00M | -$561.00M | -$721.00M | -$486.00M | -$562.00M | -$674.00M | -$883.00M | -$647.00M | -$807.00M | -$691.00M | -$706.00M | -$567.00M |
| QoQ Change | — | -307.0% | +55.8% | +11.1% | -76.9% | +4.0% | +33.0% | -9.8% | -5.4% | -15.7% | -28.5% | +32.6% | -15.6% | -19.9% | -31.0% | +26.7% | -24.7% | +14.4% | -2.2% | +19.7% |
| YoY Change | — | — | — | — | -183.0% | +33.2% | -1.2% | -25.0% | +25.5% | +10.2% | -72.1% | -5.7% | -15.9% | -20.1% | -22.5% | -33.1% | -43.6% | -2.5% | +20.0% | +12.4% |